Products and Resources Catalog

The fight against COVID-19 continues throughout the U.S., increasing stress and anguish among vulnerable populations struggling with substance use. Among those vulnerable populations, pregnant women present major concerns as they face an increase in adversity during the wake of the global pandemic. It is a difficult time for everyone, especially those facing more adversities such as pregnant women. Health providers and mental health providers must be highly vigilant in caring for pregnant women and should consider providing the following tools and resources, according to American Society of Addiction Medicine. Download the Substance Use and Pregnancy During COVID-19 factsheet for more information and resources. La lucha contra el COVID-19 continúa en los Estados Unidos, aumentando el estrés y la angustia entre poblaciones vulnerables que luchan contra el uso de sustancias. Entre esas poblaciones vulnerables, las mujeres embarazadas presentan grandes preocupaciones al enfrentar un aumento de adversidad durante el despertar de la pandemia global. Es un momento difícil para todos, especialmente aquellos que enfrentan más adversidades como las mujeres embarazadas. Los proveedores de salud y de salud mental deben estar muy atentos al cuidar a las mujeres embarazadas y deben considerar proporcionar las siguientes herramientas y recursos, según la Sociedad Americana de Medicina de la Adiccion.  Descargue la hoja informativa Uso de Sustancias y Embarazo Durante COVID-19 para obtener más información y recursos. A luta contra a COVID-19 ainda continua nos Estados Unidos, aumentando o estresse e a angústia entre as populações vulneráveis ​que lutam contra o uso de substâncias. Entre essas populações vulneráveis, as mulheres grávidas apresentam grandes preocupações porque elas enfrentam um aumento da adversidade durante o despertar de uma pandemia global. É um momento difícil para todos, especialmente para aqueles que enfrentam mais adversidades, como as mulheres grávidas. Provedores de saúde e profissionais de saúde mental devem estar altamente vigilantes ao cuidar de mulheres grávidas e devem considerar fornecer as seguintes ferramentas e recursos, de acordo com a Sociedade Americana de Dependência Química. Baixe o folheto informativo USO DE SUBSTÂNCIAS E A GRAVIDEZ DURANTE COVID-19 para obter mais informações e recursos.

Addressing Stigma and Substance Use Disorders: A HealtheKnowledge Course DESCRIPTION This course is designed to serve a broad audience including: health care and behavioral health administrators and supervisors; direct care providers of behavioral health service; and students in pre-service classes. This course provides content valuable for myriad professionals to consider in their day-to-day work when serving people with substance use disorders. The topics selected will allow participants to gain a deeper understanding of the nature and context of stigma. The four-hour course includes five 45-minute video modules on topics related to stigma in the SUD field. There is a quiz after each module. Once you have completed the 5 modules and passed the quizzes with a score of 80% or better, you will be able to access a certificate of course completion. This course represents 4.0 continuing education hours or credits, which are available from NAADAC.        Module 1: Stigma of Substance Use Disorders: An Overview Module 2: Addressing SUD & Structural Stigma: Opportunities & Challenges Module 3: Stigmata - Stigma of Medications for Opioid Use Disorder Module 4: The Stigma is Real: Pregnant and Parenting Women with Substance Use Disorders Module 5: Stigma and Substance Use Disorders: A Historical Walk   Click Here to Register

Maryland Reproductive Health Virtual Series: Implementing SBIRT: Family Planning and Reproductive Health Settings Description: The 2020 Maryland Reproductive Health Roundtable Virtual Series was a statewide, multiple sessions series spanning across three months to share education and information around reproductive health and family planning in the state of Maryland. These sessions invited public health professionals and clinical providers from city, county, and state agencies as well as health care institutions, community-based organizations, and academic partners. The topics addressed were based on priority challenges and opportunities in reproductive health care. Recordings of the sessions are below as well as corresponding resources. The 2020 Maryland Reproductive Health Roundtable Virtual Series was hosted by B’more for Healthy Babies, UChoose, Maryland Department of Health, and Morgan State University. Speakers: Holly Ireland, LCSW-C Holly is the Co-Project Director of the Central East ATTC. She has 30 years’ experience working in the behavioral health field, beginning her career as a Residential Rehabilitation Counselor while working on her undergraduate degree in psychology at Towson University. During her career, she has provided direct service in outpatient behavioral health and recovery support settings, including individual, group and family therapy for co-occurring disorders, crisis intervention, trauma treatment, Assertive Community Treatment, and advocacy. Holly also serves as adjunct faculty for Salisbury University’s Social Work Department, teaching social welfare policy and advanced practice courses.   Shelley Miller, MS Shelley Miller has worked in family planning and reproductive health for more than 35 years. She has served in a variety of roles including Director of Patient Services for a large Title X agency and Director of Training Performance Improvement for TRAINING 3, a regional training center. Shelley has provided consultation, coaching, training and technical assistance, both nationally and internationally. She currently works with the Central East ATTC as an independent consultant in its SBIRT implementation project with Title X.      

The My Reproductive Life Goals Tri-fold is a tool designed for providers engage in a conversation about reproductive/sexual health and recovery goals with women with Substance Use disorders. If you would like the Publisher version to customize the brochure with your logo, please contact Bree at [email protected]. 

This final session briefly reviews the prior training content and gets into more detail about caring for the substance exposed newborn and infant. In this session there was more time for discussion, Q&A, and problem solving based on actual cases, which was provided by the attendees.

The third session will discuss what is currently known about the risks to early infant development after prenatal substance exposures and how to provide care and treatment to optimize outcomes.

This second session will go into detail about newborn opioid withdrawal, how the presentation may differ from other substance exposures, and the impact of poly-substance exposure. We will discuss care and treatment of the newborn after delivery and the potential impact on longer-term outcomes.

This webinar provides background information on substance use disorders and mental health conditions in women of child-bearing age and how these conditions may impact the woman and her fetus during pregnancy, the newborn, and long-term outcomes. Presentations and discussions focus on the practical, clinical application of the material when caring for the substance-exposed newborn and the family.

This webinar will provide an in-depth examination of the stigma women with substance use disorders (SUDs) who are pregnant and/or parenting encounter when seeking healthcare services. Strategies to reduce barriers related to stigmatizing attitudes and practices will be addressed.      

The Opioid Response Network and Mid-America ATTC have partnered to produce the Perinatal Provider Toolkit. It is a centralized online reference to help health care providers quickly access reputable resource information on perinatal substance use for patient treatment and education. The toolkit is for any member of the healthcare team serving pregnant and postpartum women with substance use disorders (SUD). Resources are organized into healthcare provider guidance and patient education tools that providers can use to explain the health effects of perinatal substance use to their patients. Resources cover the full spectrum of substances, including alcohol, opioids, marijuana, methamphetamine, tobacco, and others.

The Family Recovery Pathways conference was held in Sioux Falls, SD on May 6-8, 2019, developed by the HHS Region 7 Mid-America Addiction Technology Transfer Center (Mid-America ATTC) and HHS Region 8 Mountain Plains Addiction Technology Transfer Center (Mountain Plains ATTC). This conference also had support from the Region 8 Mountain Plains Prevention Technology Transfer Center (Mountain Plains PTTC) and the ATTC Network Coordinating Office. The goal of the Family Recovery Pathways conference was to bring together professionals who engage with families impacted by substance use disorders to learn best practices in working in the child welfare and substance use disorder system. A total of 275 people representing 20 states attended throughout the three-day conference. Conference presentations featured more than 50 presenters and panelists addressing such topics as Adverse Childhood Experiences, Policy Approaches to Support Family-Centered Care, and Pregnancy and Parenting in the Midst of a Methamphetamine Epidemic. Presentations are available for download by clicking https://attcnetwork.org/centers/mountain-plains-attc/bring-them-all

This webinar, sponsored by the Northwest ATTC and the Western States Node of the NIDA CTN, summarized what makes women's treatment for opioid use disorder (OUD) or other substance use disorders unique from men's treatment, and highlighted key issues when providing treatment to pregnant and parenting women with opioid use and other SUDs. Presenters: Hendree Jones, PhD (Executive Director, UNC Horizons; Professor OBGYN, UNC Chapel Hill) and Carl Seashore, MD (Professor of Pediatrics, UNC Chapel Hill) Download slides | Watch recording Webinar category: Specific populations

This presentation described a simple screening tool for pregnancy intention. One Key Question was originally developed by and is the intellectual property of the Oregon Foundation for Reproductive Health. Presented by Sounivone Phanthavong.

This training presentation address Medication Assisted Treatment for Pregnant or Parenting Women Offenders with a Substance Use Disorder.